Warning: The NCBI web site requires JavaScript to function. more...
Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects.
Chuang CM, Monie A, Wu A, Hung CF.
J Biomed Sci. 2009 May 27;16:49.
Related citations
Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts.
Tseng CW, Trimble C, Zeng Q, Monie A, Alvarez RD, Huh WK, Hoory T, Wang MC, Hung CF, Wu TC.
Cancer Immunol Immunother. 2009 May;58(5):737-48. Epub 2008 Sep 25.
Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects.
Tseng CW, Monie A, Trimble C, Alvarez RD, Huh WK, Buchsbaum DJ, Straughn JM Jr, Wang MC, Yagita H, Hung CF, Wu TC.
Vaccine. 2008 Aug 12;26(34):4314-9. Epub 2008 Jul 1.
Comparison of HPV DNA vaccines employing intracellular targeting strategies.
Kim JW, Hung CF, Juang J, He L, Kim TW, Armstrong DK, Pai SI, Chen PJ, Lin CT, Boyd DA, Wu TC.
Gene Ther. 2004 Jun;11(12):1011-8.
Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination.
Chuang CM, Monie A, Hung CF, Wu TC.
J Biomed Sci. 2010 Apr 28;17:32.
DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens.
Huang CY, Chen CA, Lee CN, Chang MC, Su YN, Lin YC, Hsieh CY, Cheng WF.
Gynecol Oncol. 2007 Dec;107(3):404-12. Epub 2007 Oct 1.
Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines.
Hauser H, Shen L, Gu QL, Krueger S, Chen SY.
Gene Ther. 2004 Jun;11(11):924-32.
Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells.
Chuang CM, Hoory T, Monie A, Wu A, Wang MC, Hung CF.
Vaccine. 2009 Jan 29;27(5):684-9. Epub 2008 Dec 3.
Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect.
Pokorná D, Macková J, Dusková M, Rittich S, Ludvíková V, Smahel M.
J Gene Med. 2005 Jun;7(6):696-707.
Therapeutic synergy of human papillomavirus E7 subunit vaccines plus cisplatin in an animal tumor model: causal involvement of increased sensitivity of cisplatin-treated tumors to CTL-mediated killing in therapeutic synergy.
Bae SH, Park YJ, Park JB, Choi YS, Kim MS, Sin JI.
Clin Cancer Res. 2007 Jan 1;13(1):341-9.
Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe.
Trimble C, Lin CT, Hung CF, Pai S, Juang J, He L, Gillison M, Pardoll D, Wu L, Wu TC.
Vaccine. 2003 Sep 8;21(25-26):4036-42.
Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination.
Tseng CW, Monie A, Wu CY, Huang B, Wang MC, Hung CF, Wu TC.
J Mol Med (Berl). 2008 Aug;86(8):899-908. Epub 2008 Jun 10.
Characterization of HPV-16 E6 DNA vaccines employing intracellular targeting and intercellular spreading strategies.
Peng S, Trimble C, Ji H, He L, Tsai YC, Macaes B, Hung CF, Wu TC.
J Biomed Sci. 2005 Oct;12(5):689-700. Epub 2005 Nov 9.
Induction of CD4-independent E7-specific CD8+ memory response by heat shock fusion protein.
Liu H, Wu BH, Rowse GJ, Emtage PC.
Clin Vaccine Immunol. 2007 Aug;14(8):1013-23. Epub 2007 Jun 27.
Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines.
Peng S, Monie A, Pang X, Hung CF, Wu TC.
J Biomed Sci. 2011 Mar 8;18:21.
Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.
Cheng WF, Hung CF, Chai CY, Hsu KF, He L, Ling M, Wu TC.
J Clin Invest. 2001 Sep;108(5):669-78.
Control of cervicovaginal HPV-16 E7-expressing tumors by the combination of therapeutic HPV vaccination and vascular disrupting agents.
Zeng Q, Peng S, Monie A, Yang M, Pang X, Hung CF, Wu TC.
Hum Gene Ther. 2011 Jul;22(7):809-19. Epub 2011 Mar 9.
A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis.
Liu B, Ye D, Song X, Zhao X, Yi L, Song J, Zhang Z, Zhao Q.
Vaccine. 2008 Mar 4;26(10):1387-96. Epub 2008 Jan 22.
Enhancement of DNA vaccine potency by coadministration of a tumor antigen gene and DNA encoding serine protease inhibitor-6.
Kim TW, Hung CF, Boyd DA, He L, Lin CT, Kaiserman D, Bird PI, Wu TC.
Cancer Res. 2004 Jan 1;64(1):400-5.
A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity.
Lin CT, Tsai YC, He L, Calizo R, Chou HH, Chang TC, Soong YK, Hung CF, Lai CH.
J Biomed Sci. 2006 Jul;13(4):481-8. Epub 2006 Apr 29.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on